(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
@ $1.986
Issued: 9 Feb 2024 @ 15:25
Return: -28.80%
Live Chart Being Loaded With Signals
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens...
Stats | |
---|---|
Today's Volume | 46 491.00 |
Average Volume | 1.17M |
Market Cap | 2.23M |
EPS | $0 ( 2024-04-10 ) |
Next earnings date | ( $0 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0900 |
ATR14 | $0.0110 (0.78%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2008-05-08 | Carter Stephen | Sell | 10 000 | Common Stock |
2008-05-08 | Lokay Kevin G | Sell | 185 439 | Common Stock |
2008-05-08 | Lokay Kevin G | Sell | 100 000 | Options to Purchase Common Stock |
2008-05-08 | Mollica Joseph A | Sell | 10 000 | Common Stock |
2007-11-13 | Lokay Kevin G | Buy | 500 000 | Options to purchase Common Stock par value $0.01 |
INSIDER POWER |
---|
0.00 |
Last 33 transactions |
Buy: 1 218 228 | Sell: 315 439 |
Volume Correlation
Altamira Therapeutics Correlation
10 Most Positive Correlations | |
---|---|
PIII | 0.951 |
PROC | 0.95 |
DISH | 0.948 |
LGMK | 0.945 |
AHCO | 0.944 |
LGHL | 0.942 |
EVLO | 0.942 |
TTEC | 0.941 |
MDRX | 0.941 |
UPC | 0.94 |
10 Most Negative Correlations | |
---|---|
VKTX | -0.965 |
JMAC | -0.965 |
IQ | -0.96 |
DKDCA | -0.96 |
CMPO | -0.957 |
HHGC | -0.956 |
IVCP | -0.956 |
AIB | -0.951 |
OVLY | -0.951 |
ACLS | -0.951 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Altamira Therapeutics Correlation - Currency/Commodity
Altamira Therapeutics Financials
Annual | 2022 |
Revenue: | $305 616 |
Gross Profit: | $-1.14M (-372.44 %) |
EPS: | $-29.13 |
Q2 | 2023 |
Revenue: | $115 639 |
Gross Profit: | $-182 406 (-157.74 %) |
EPS: | $-1.420 |
Q2 | 2022 |
Revenue: | $1.29M |
Gross Profit: | $-30 361.00 (-2.34 %) |
EPS: | $-9.98 |
Q2 | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-9.14 |
Financial Reports:
No articles found.
Altamira Therapeutics
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treatment of acute inner ear hearing loss. It operates in Switzerland, the United States, Europe, and Australia. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators